FEAR: Face Everything and Rise (in Clinical Research)

David Burrow, PharmD, JD, explored foundational principles of Quality by Design (QbD), including Critical to Quality (CTQ) factors and Risk-Based Quality Management Systems (RBQM). Participants gained strategic insights into how to enhance trial quality while reducing regulatory uncertainty through forward-thinking approaches and practical tools.

Crack the Code: A Comparison of ICH E6(R2) and ICH E6(R3)

This 60-minute webinar is designed to help clinical research, regulatory affairs, and GCP quality professionals decode the complexities of the updated guidance. The speaker breaks down the key shifts, themes, and differences between R2 and R3, provides real-world examples to simplify the changes, and introduces a framework to help identify gaps and prioritize the next steps for compliance.